Kitabis Pak inhalation

Generic name: Tobramycin (inhalation)

Usage of Kitabis Pak inhalation

Kitabis Pak is an antibiotic that is inhaled into the lungs using a nebulizer. This medicine inhalation is used to treat lung infections in patients with cystic fibrosis.

Kitabis Pak is for use in adults and children who are at least 6 years old.

Kitabis Pak may also be used for purposes not listed in this medication guide.

Kitabis Pak inhalation side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Kitabis Pak may cause serious side effects. Call your doctor at once if you have:

new or worsening breathing problems, such as wheezing, cough, chest tightness, or trouble breathing;

hearing problems, ringing in your ears;

hoarse voice;

severe dizziness, spinning sensation, balance problems;

weak or shallow breathing;

muscle weakness; or

kidney problems--little or no urination, swelling in your feet or ankles, feeling tired or short of breath.

Common side effects of Kitabis Pak may include:

cough, sore throat, hoarse voice;

feeling short of breath;

noisy breathing;

worsening of lung problems or cystic fibrosis;

coughing up mucus or blood;

altered sense of taste;

fever;

headache; or

rash.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Kitabis Pak inhalation

You should not use Kitabis Pak if you are allergic to Kitabis Pak or similar antibiotics (amikacin, gentamicin, kanamycin, neomycin, paromomycin, streptomycin).

Tell your doctor if you have ever had:

hearing problems;

breathing problems (cough, wheezing, chest tightness);

dizzy spells;

a neuromuscular disease such as myasthenia gravis or Parkinson's disease; or

kidney disease.

It is not known whether Kitabis Pak will harm an unborn baby. However, a medicine similar to this medicine caused irreversible hearing damage in babies whose mothers took that medicine during pregnancy.

Tell your doctor if you are pregnant or plan to become pregnant. Having cystic fibrosis during pregnancy may increase the risk of premature birth. The benefit of treating cystic fibrosis may outweigh any risks to the baby.

If you breastfeed while using Kitabis Pak, watch the baby for signs of diarrhea, blood in the stools, or a fungal diaper rash with white patches on the skin.

Kitabis Pak is not approved for use by anyone younger than 6 years old.

How to use Kitabis Pak inhalation

Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.

Kitabis Pak is inhaled into the lungs with the use of a nebulizer or an inhaler device. Do not swallow the medicine by mouth.

Use only the inhaler device provided with your medicine.

Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you do not understand these instructions.

Kitabis Pak is given in a treatment cycle of 28 days on and 28 days off. Follow your doctor's dosing instructions very carefully. Keep using this medicine on this schedule, even if you feel fine.

Use your doses at regular intervals of 12 hours apart but not less than 6 hours apart.

If you use other inhaled medicines, or if you perform chest physiotherapy to remove mucus from the lungs, use these other treatments first before using your Kitabis Pak dose.

Do not use Kitabis Pak solution if it looks cloudy or has particles in it. Call your pharmacist for new medicine.

Store Kitabis Pak ampules in the refrigerator between 36 and 46 degrees Fahrenheit (2 and 8 degrees Celsius).

If refrigeration is not available, store the ampules at cool room temperature for up to 28 days. Protect from light. The solution may become darker in color at room temperature, but this should not affect the quality of the medicine.

Store Tobi Podhaler capsules in their original blister pack at room temperature away from moisture and heat. Remove a Tobi Podhaler capsule from the blister pack only when you are ready to load it into your inhaler device.

Warnings

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

What other drugs will affect Kitabis Pak inhalation

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects.

Tell your doctor about all your other medicines, especially:

urea;

a diuretic or "water pill"--furosemide, Lasix, ethacrynic acid, and others;

Kitabis Pak or similar medicines (taken by mouth or injected)--amikacin, kanamycin, neomycin, paromomycin, plazomicin, streptomycin; or

other medicine that may harm your kidneys, hearing, or nervous system--certain medicines for infections, cancer, osteoporosis, organ transplant rejection, bowel disorders, high blood pressure, or pain or arthritis (including Advil, Motrin, and Aleve).

This list is not complete. Other drugs may affect Kitabis Pak, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.